Genetic Technologies granted approval for pancreatic cancer, melanoma and atrial fibrillation testing
Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) confirms that its expanded geneType Multi-Risk Test, to include three new diseases —...